Spamdex - Spam Archive

Report spam

Send in your spam and get the offenders listed

Create a rule in outlook or simply forward the spam you receive to questions@spamdex.co.uk

Also in kaiserhealthnews.org

KHN First Edition: September 21, 2016

KHN

First Edition

Wednesday, September 21, 2016
Check Kaiser Health News online for the latest headlines

Today's early morning highlights from the major news organizations.

Kaiser Health News: Would You Like Some Insurance With Your Insurance?
Side Effects Public Media's Bram Sable-Smith, in partnership with KHN and NPR, reports: "For the first time in her life, 26-year-old freelance designer Susannah Lohr had to shop for health insurance this year. She called up a major insurer in the St. Louis area where she lives, and it offered her a plan with a hefty $6,000 deductible — that’s the amount she would have to cover herself before the insurance kicks in. When she balked, the salesman on the phone suggested that she could buy a “gap plan,” a separate policy for $50 a month to cover her deductible." (Sable-Smith, 9/21)

California Healthline: Veterans Courted In California’s Ballot Fight Over Curbing Drug Prices
California Healthline's Pauline Bartolone writes: "Once a month at the Veterans of Foreign Wars building in Sacramento, a couple dozen former soldiers, many with white hair tucked under their service caps, stand and salute as they take up matters close to their communities.For discussion at a recent meeting: proper burial services for homeless veterans and a Harley Davidson motorcycle BBQ fundraiser. Also on the agenda: California’s Proposition 61 — a controversial measure on the November ballot that aims to rein in prescription drug prices." (Bartolone, 9/21)

The Associated Press: Mylan CEO Set To Defend EpiPen Prices Amid Public Outcry
The head of pharmaceutical company Mylan is defending the cost for life-saving EpiPens, signaling the company has no plans to lower prices despite a public outcry and questions from skeptical lawmakers. "Price and access exist in a balance, and we believe we have struck that balance," Heather Bresch says in prepared testimony released by the House Oversight and Government Reform Committee ahead of her Wednesday appearance before the panel. (9/21)

Reuters: Medicare EpiPen Spending Outpaces Prescription Growth: Kaiser Report
U.S. government spending on Mylan Inc's EpiPen in the Medicare program for seniors and the disabled rose 1,151 percent from 2007 through 2014, while the number of EpiPen users grew 164 percent, the Kaiser Family Foundation said on Tuesday in an analysis. The spending figure excludes after-market manufacturer rebates that Mylan paid to the private insurers who manage the Medicare Part D program for pharmacy drugs on behalf of the government, it said. (Humer, 9/20)

Reuters: U.S. Senate Finance Committee Asks For Mylan EpiPen Rebate Investigation
The U.S. Senate Finance Committee on Tuesday said it had asked the U.S. Department of Health and Human Services to investigate the rebates to state Medicaid programs for Mylan Inc's EpiPen treatment. Mylan, which has raised the U.S. price for a pack of two EpiPens from less than $100 when it acquired the product in 2007 to more than $600, also faces scrutiny from New York Attorney General Eric Schneiderman and West Virginia. (Humer, 9/20)

USA Today: W.Va. Seeks Mylan Records On EpiPen Price Hikes
West Virginia's top legal official Tuesday sought court enforcement of a subpoena that seeks answers from Mylan N.V. (MYL) about spiraling price hikes the pharmaceutical company imposed for its EpiPen lifesaving allergy injectors. Filed on the eve of congressional hearings scheduled over the increases, the court petition is part of an investigation that could lead to Medicaid fraud charges against the Europe-based company. (McCoy, 9/20)

Reuters: Mylan Shares Languish At Low Valuation As EpiPen Hearing Nears
Shares of Mylan NV are trading at historically low valuations as the company's chief executive officer is set to face a congressional grilling on Wednesday over the price of its EpiPen emergency allergy treatment. The stock is trading at 7.5 times estimated earnings for the next 12 months, holding near its lowest in at least 30 years and well below its five-year average of 11 times, according to Thomson Reuters Datastream. (Krauskopf, 9/20)

The Associated Press: Slow Progress On Bill To Battle Zika And Prevent Shutdown
Top congressional leaders said Tuesday that negotiators are making slow but steady progress on a must-do spending bill to prevent a government shutdown next week and fund the battle against the Zika virus. Some tricky issues remain, but optimism was building that an agreement might be unveiled in the next day or two. Congressional aides said that progress included an offer from Republicans to drop especially controversial provisions that would have eased pesticide regulations under the Clean Water Act and blocked tighter regulations on the length of workweeks for truckers. (Taylor, 9/20)

The Washington Post: Turmoil At Federal Agency Threatens Oversight Of Biomedical Research
A small government office that monitors misconduct in biomedical research is in turmoil, jeopardizing oversight of billions of dollars in grants to universities and other institutions around the country. Six of the eight investigators in the federal Office of Research Integrity have signed a letter hinting that they may leave, a move that could hobble federal efforts to detect data ma­nipu­la­tion and other misconduct by laboratory researchers. The office’s new head has filed personnel actions against the two division directors she inherited and installed a new deputy to supervise the entire staff. (Bernstein, 9/20)

The Washington Post: ‘Superbug’ MRSA May Be Spreading Through Tainted Poultry
A new form of a dangerous "superbug" may be spreading to humans through contaminated poultry that people handle or eat, according to a study published Wednesday. Researchers focused on a newly identified strain of the bacterium known as MRSA, or methicillin-resistant Staphylococcus aureus, that they found in people in Denmark. Although most individuals who become infected with MRSA don't get it from food, the study suggests that this poultry-associated strain may be more easily transmitted from food to people. (Sun, 9/21)

NPR: How To Get More Doctors To Treat People With Opioid Addiction
Many people struggling with opioid addiction can't find a doctor to provide medication-assisted treatment, even though it's highly effective. One reason could be that doctors who are qualified to prescribe the medication typically treat just a handful of patients. (Shute, 9/20)

Los Angeles Times: Seattle's New War On Drugs: Giving Heroin Addicts 'Safe Sites' To Shoot Up
Seattle officials are moving forward with a controversial plan for what would be the nation’s first supervised heroin-injection clinics — government-financed shooting galleries that supporters say can save lives but that critics say will only enable drug users. A new 99-page task force study envisions at least two safe-use facilities — one in Seattle, another in the suburbs — where heroin addicts can legally take narcotics while being monitored by medical personnel who can administer aid or call 911 if needed. (Anderson, 9/21)

The Wall Street Journal: Allergan To Buy Tobira Therapeutics In $1.7 Billion Deal
Allergan PLC on Tuesday said it agreed to acquire Tobira Therapeutics Inc., a biopharmaceutical company that develops therapies for liver diseases, in a deal worth as much as $1.7 billion, or 19 times Tobira’s previous market value. Tobira focuses on products that treat nonalcoholic steatohepatitis, or NASH, a common liver disease associated with obesity and type-2 diabetes. NASH occurs when the accumulation of liver fat is accompanied by inflammation and cellular damage, and it can lead to scarring of the liver and progress to cirrhosis, liver cancer and eventual liver failure. (Stynes, 9/20)

USA Today/Milwaukee Journal Sentinel: Effort Fights ‘Epidemic’ Of Deadly Elderly Falls
Elderly people seldom want to talk about it.It’s scary, and if it’s happened to them and they’ve survived, they’re often embarrassed. And worried. One time too many and — whoosh — it’s off to a nursing home.But it’s happening more and more: People 65 and older are falling and an increasing number are dying as a result. Nationally, the rate of death after a fall jumped more than 35% between 2005 and 2014. (Rutledge, 9/20)

Los Angeles Times: Men With Anxiety Are More Vulnerable To Cancer, Study Says
Men over 40 who are plagued with the omnipresent of generalized anxiety disorder are more than twice as likely to die of cancer than are men who do not have the mental affliction, new research finds. But for women who suffer from severe anxiety, the research found no increased risk of cancer death. That finding, presented Tuesday at the European College of Neuropsychopharmacology’s Congress in Vienna, emerges from the largest study ever to explore a link between anxiety and cancer. It tracked 15,938 Britons over 40 for 15 years. (Healy, 9/20)

NPR: Fitness Trackers Didn't Help People Lose Weight
Fitness trackers remain wildly popular, but do they make us fit? Maybe not, according to a study that asked overweight or obese young adults to use the tiny tracking tools to lose weight. The 470 people in the study were put on a low-calorie diet and asked to exercise more. They all started losing weight. Six months in, half the group members started self-reporting their diet and exercise. The other half were given fitness trackers to monitor their activity. After two years, both groups were equally active. But the people with the fitness trackers lost less weight. (Ross, 9/20)

The New York Times: Orlando’s Latest Theme Park Is A City For Wellness
Orlando is trying to show itself as a place far different than a land of fantasy. An important part of Orlando’s emerging presence as a mature and innovative city is the 14-square-mile Lake Nona project, which is being built on land that only a decade ago was mostly pasture. Once finished, the development, being built by Tavistock Development Company, will resemble a city in everything but name, with hospitals, hotels, office buildings, schools and colleges, recreational and sports training facilities, retail centers, entertainment spots and, ultimately, about 11,000 homes and more than 25,000 residents. (Madigan, 9/20)

Kaiser Health News is an editorially independent operating program of the Kaiser Family Foundation. (c) 2016 Kaiser Health News. All rights reserved.

Follow us on Twitter | Facebook | LinkedIn

You are subscribed to this email alert as .

Update your email preferences to choose the types of emails you receive. Or, permanently unsubscribe from all emails.

If you need help or have questions, please send an email to subscriptions@kaiserhealthnews.org
Please do not reply to this email as this address is not monitored.

 

Kaiser Family Foundation & Kaiser Health News | 2400 Sand Hill Road | Menlo Park, CA 94025


---------------------------

All titles, content, publisher names, trademarks, artwork, and associated imagery are trademarks and/or copyright material of their respective owners. All rights reserved. The Spam Archive website contains material for general information purposes only. It has been written for the purpose of providing information and historical reference containing in the main instances of business or commercial spam.

Many of the messages in Spamdex's archive contain forged headers in one form or another. The fact that an email claims to have come from one email address or another does not mean it actually originated at that address! Please use spamdex responsibly.


Yes YOU! Get INVOLVED - Send in your spam and report offenders

Create a rule in outlook or simply forward the junk email you receive to questions@spamdex.co.uk | See contributors

Google + Spam 2010- 2017 Spamdex - The Spam Archive for the internet. unsolicited electric messages (spam) archived for posterity. Link to us and help promote Spamdex as a means of forcing Spammers to re-think the amount of spam they send us.

The Spam Archive - Chronicling spam emails into readable web records index for all time

Please contact us with any comments or questions at questions@spamdex.co.uk. Spam Archive is a non-profit library of thousands of spam email messages sent to a single email address. A number of far-sighted people have been saving all their spam and have put it online. This is a valuable resource for anyone writing Bayesian filters. The Spam Archive is building a digital library of Internet spam. Your use of the Archive is subject to the Archive's Terms of Use. All emails viewed are copyright of the respected companies or corporations. Thanks to Benedict Sykes for assisting with tech problems and Google Indexing, ta Ben.

Our inspiration is the "Internet Archive" USA. "Libraries exist to preserve society's cultural artefacts and to provide access to them. If libraries are to continue to foster education and scholarship in this era of digital technology, it's essential for them to extend those functions into the digital world." This is our library of unsolicited emails from around the world. See https://archive.org. Spamdex is in no way associated though. Supporters and members of http://spam.abuse.net Helping rid the internet of spam, one email at a time. Working with Inernet Aware to improve user knowlegde on keeping safe online. Many thanks to all our supporters including Vanilla Circus for providing SEO advice and other content syndication help | Link to us | Terms | Privacy | Cookies | Complaints | Copyright | Spam emails / ICO | Spam images | Sitemap | All hosting and cloud migration by Cloudworks.

Important: Users take note, this is Spamdex - The Spam Archive for the internet. Some of the pages indexed could contain offensive language or contain fraudulent offers. If an offer looks too good to be true it probably is! Please tread, carefully, all of the links should be fine. Clicking I agree means you agree to our terms and conditions. We cannot be held responsible etc etc.

The Spam Archive - Chronicling spam emails into readable web records

The Glass House | London | SW19 8AE |
Spamdex is a digital archive of unsolicited electronic mail 4.9 out of 5 based on reviews
Spamdex - The Spam Archive Located in London, SW19 8AE. Phone: 08000 0514541.